SCHEMBL24319641

SCHEMBL24319641

CN1CCC(CN2CC3CCN(C)CC3C2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.43
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38
GNAI1 P63096 1/20 0.38
SCN1A P35498 1/20 0.37
SCN4A P35499 1/20 0.37
SCN7A Q01118 1/20 0.37
KCNH2 Q12809 1/20 0.37
SCN5A Q14524 1/20 0.37
SCN9A Q15858 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
SCN11A Q9UI33 1/20 0.37
SCN8A Q9UQD0 1/20 0.37
SCN10A Q9Y5Y9 1/20 0.37
CACNA2D1 P54289 1/20 0.35
CACNA1B Q00975 1/20 0.35
CACNB1 Q02641 1/20 0.35
CACNA1C Q13936 1/20 0.35
CHRM5 P08912 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24319173 1.00 NCF1 (0.43) NCF1GNAI3GNAO1GNAI1SCN1A
SCHEMBL24319344 0.94 NCF1 (0.45) NCF1GNAI3GNAO1GNAI1SCN1A
SCHEMBL22565080 0.94 NCF1 (0.45) NCF1GNAI3GNAO1GNAI1SCN1A
SCHEMBL24319846 0.92 NCF1 (0.41) NCF1GNAI3GNAO1GNAI1SCN1A
SCHEMBL24319179 0.85 GBA1 (0.47) NCF1GNAI3GNAO1GNAI1SCN1A
SCHEMBL24480584 0.84 NCF1 (0.37) NCF1GNAI3GNAO1GNAI1CACNA2D1
SCHEMBL17285958 0.83 SCN1A (0.42) NCF1SCN1ASCN4ASCN7AKCNH2
SCHEMBL10196619 0.83 SCN1A (0.42) NCF1SCN1ASCN4ASCN7AKCNH2
SCHEMBL21946682 0.82 NCF1 (0.38) NCF1GNAI3GNAO1GNAI1SCN1A
SCHEMBL25074351 0.81 GNAI3 (0.50) NCF1GNAI3GNAO1GNAI1CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed